Functional characterization of a novel somatic oncogenic mutation of PIK3CB. Signal Transduction and Targeted Therapy, 2017 by Reaction Biology | Jul 6, 2023
Cell lines expressing recombinant transmembrane domain-activated receptor kinases as tools for drug discovery. Journal of Biomolecular Screening, 2014 by Reaction Biology | Jul 6, 2023
Establishment of a methodological platform for the exploration of MCL1 inhibitors by Reaction Biology | Jul 6, 2023
